These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30639826)

  • 1. Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaire.
    Beckmann H; Augustin M; Heesen C; Poettgen J; Blome C
    Mult Scler Relat Disord; 2019 Feb; 28():256-261. PubMed ID: 30639826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: item response theory modelling and confirmatory factor analysis.
    Ballesteros J; Moral E; Brieva L; Ruiz-Beato E; Prefasi D; Maurino J
    Health Qual Life Outcomes; 2017 Apr; 15(1):79. PubMed ID: 28431587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
    Baumstarck K; Pelletier J; Boucekine M; Auquier P;
    Rev Neurol (Paris); 2015 Feb; 171(2):173-80. PubMed ID: 25558798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.
    Wicks P; Vaughan TE; Massagli MP
    Health Qual Life Outcomes; 2012 Jun; 10():70. PubMed ID: 22709981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Relapse Knowledge in People with Multiple Sclerosis: A Cross-Sectional Study on the Development and Validation of the Relapse Knowledge Questionnaire.
    Wenzel L; Haker M; Heesen C; Kasper J; Köpke S; Rahn AC
    Mult Scler Relat Disord; 2024 Mar; 83():105381. PubMed ID: 38308915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
    Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
    Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the Patient Benefit Index for peripheral arterial disease.
    Zander N; Demirel EB; Augustin M; Sommer R; Debus ES; Breuer P; Blome C
    Vasa; 2018 Apr; 47(3):219-226. PubMed ID: 29366378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of patient-relevant outcomes of lymphedema and lipedema treatment: development and validation of a new benefit tool.
    Blome C; Augustin M; Heyer K; Knöfel J; Cornelsen H; Purwins S; Herberger K
    Eur J Vasc Endovasc Surg; 2014 Jan; 47(1):100-7. PubMed ID: 24239143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
    Pakdaman H; Amini Harandi A; Gharagozli K; Abbasi M; Tabassi A; Ashrafi F; Ghaffarpor M; Sharifi S; Delavar Kasmae H; Assarzadegan F; Arabahmadi M; Behnam B
    Int J Neurosci; 2017 Jun; 127(6):501-507. PubMed ID: 27279451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 27-Item Multiple Sclerosis Quality of Life Questionnaire: A New Brief Measure Including Treatment Burden and Work Life.
    Beckmann H; Heesen C; Augustin M; Blome C
    Int J MS Care; 2022; 24(4):147-153. PubMed ID: 35875460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q).
    Ruiz MA; Pardo A; Rejas J; Soto J; Villasante F; Aranguren JL
    Value Health; 2008; 11(5):913-26. PubMed ID: 18494753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
    Baumstarck K; Pelletier J; Butzkueven H; Fernández O; Flachenecker P; Idiman E; Stecchi S; Boucekine M; Auquier P;
    Eur J Neurol; 2013 Jun; 20(6):907-14, e78-9. PubMed ID: 23347258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue during multiple sclerosis relapse and its relationship to depression and neurological disability.
    Šabanagić-Hajrić S; Suljić E; Kučukalić A
    Psychiatr Danub; 2015 Dec; 27(4):406-12. PubMed ID: 26609654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial.
    Robinson D; Zhao N; Gathany T; Kim LL; Cella D; Revicki D
    Curr Med Res Opin; 2009 May; 25(5):1121-30. PubMed ID: 19317608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23).
    Martínez-Ginés ML; García-Domínguez JM; Forero L; Canal N; Rebollo P; Prefasi D; Honan CA; Maurino J
    Mult Scler Relat Disord; 2018 May; 22():115-119. PubMed ID: 29656271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study.
    D'hooghe M; Van Gassen G; Kos D; Bouquiaux O; Cambron M; Decoo D; Lysandropoulos A; Van Wijmeersch B; Willekens B; Penner IK; Nagels G
    Mult Scler Relat Disord; 2018 May; 22():90-96. PubMed ID: 29649789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study.
    Patti F; Russo P; Pappalardo A; Macchia F; Civalleri L; Paolillo A;
    J Neurol Sci; 2007 Jan; 252(2):121-9. PubMed ID: 17188301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis.
    Achiron A; Barak Y; Rotstein Z
    Mult Scler; 2003 Oct; 9(5):486-91. PubMed ID: 14582775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Turkish version of the eight-item actionable bladder symptom screening tool in multiple sclerosis.
    Polat Dunya C; Tulek Z; Vızvız GY; Gündüz T; Panicker JN; Kürtüncü M; Eraksoy M
    Neurourol Urodyn; 2020 Jan; 39(1):243-252. PubMed ID: 31588627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a new patient-reported outcome instrument of health-related quality of life specific to patients with alcohol use disorder: the Alcohol Quality of Life Scale (AQoLS).
    Luquiens A; Whalley D; Laramée P; Falissard B; Kostogianni N; Rehm J; Manthey J; Paille F; Aubin HJ
    Qual Life Res; 2016 Jun; 25(6):1549-60. PubMed ID: 26589528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.